Previous experiments with human lung and bladder cancer cells have confirmed that LicA can cause G2/M phase arrest by inhibiting CDC2, CDC25C, cyclin A, and cyclin B expression [31,36]. This evidence concerns the gene CDC25C and urinary bladder cancer.